| TRALI consensus panel M Goldman, KE Webert, DM Arnold, J Freedman, J Hannon, ... Proceedings of a consensus conference: towards an understanding of TRALI …, 2005 | 463 | 2005 |
| Proceedings of a consensus conference: towards an understanding of TRALI M Goldman, KE Webert, DM Arnold, J Freedman, J Hannon, ... Transfusion medicine reviews 19 (1), 2-31, 2005 | 239 | 2005 |
| Proceedings of a Consensus Conference: Pathogen Inactivation - Making Decisions About New Technologies BMA Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM Transfusion Medicine Reviews 22 (1), 1-34, 2008 | 119 | 2008 |
| Evaluation of red blood cells stored at− 80 C in excess of 10 years J Lecak, K Scott, C Young, J Hannon, JP Acker Transfusion 44 (9), 1306-1313, 2004 | 82 | 2004 |
| New genotypes in Fy (a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FYA or FYB HJ Rios M, Chaudhuri A British Journal of Hematology 108, 448-454, 2000 | 72* | 2000 |
| Damage and protection of UC blood cells during cryopreservation H Yang, JP Acker, J Hannon, H Miszta-Lane, JJ Akabutu, LE McGann Cytotherapy 3 (5), 377-386, 2001 | 56 | 2001 |
| Alloimmune red blood cell antibodies: prevalence and pathogenicity in a Canadian prenatal population R Zwingerman, V Jain, J Hannon, N Zwingerman, G Clarke Journal of Obstetrics and Gynaecology Canada 37 (9), 784-790, 2015 | 48 | 2015 |
| Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma JL Hannon, G Clarke Transfusion 55 (11), 2770-2770, 2015 | 46 | 2015 |
| Transfusion‐and community‐acquired cytomegalovirus infection in children with malignant disease: a prospective study JK Preiksaitis, S Desai, W Vaudry, S Roberts, J Akabutu, P Grundy, ... Transfusion 37 (9), 941-946, 1997 | 32 | 1997 |
| Blood preservation workshop: New and emerging trends in research and clinical practice JL Holovati, JL Hannon, MIC Gyongyossy-Issa, JP Acker Transfusion Medicine Reviews 23 (1), 25-41, 2009 | 28 | 2009 |
| Proceedings of a Consensus Conference: Blood-borne HIV and Hepatitis: Optimizing the Donor Selection Process HJL Chiavetta J, Deeks S Transfusion Medicine Reviews 17 (1), 1-30, 2003 | 28 | 2003 |
| Proceedings of a consensus conference: the screening of blood donors for variant CJD MA Blajchman, M Goldman, KE Webert, EC Vamvakas, J Hannon, ... Transfusion Medicine Reviews 18 (2), 73-92, 2004 | 27 | 2004 |
| Management of blood donors and blood donations from individuals found to have a positive direct antiglobulin test JL Hannon Transfusion medicine reviews 26 (2), 142-152, 2012 | 26 | 2012 |
| Resolving variable maternal D typing using serology and genotyping in selected prenatal patients G Clarke, J Hannon, P Berardi, G Barr, J Cote, R Fallis, T Alport, D Lane, ... Transfusion 56 (12), 2980-2985, 2016 | 18 | 2016 |
| Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: integrating science, legal duties and ethical mandates T Caulfield, J Dossetor, L Boshkov, J Hannon, D Sawyer, G Robertson CMAJ 157 (10), 1389-1392, 1997 | 14 | 1997 |
| Blocking phenomenon due to anti-Kell in post-natal investigation J Hannon, G Clarke, B Caruk, E Button Transfus Med 17, 233, 2007 | 10 | 2007 |
| Serological findings related to treatment with a human monoclonal antibody (daratumumab) in patients with advanced plasma cell myeloma JL Hannon, B Caruk, G Clarke Transfusion 54, 162A-162A, 2014 | 8 | 2014 |
| Hemolytic disease of the fetus and newborn caused by an antibody to a low‐prevalence antigen, anti‐SARA D Towns, J Hannon, J Hendry, J Barnes, M Goldman Transfusion 51 (9), 1977-1979, 2011 | 8 | 2011 |
| Anti-plasticizer specific IgE is present in the serum of transfused patients. ML Salkie, JL Hannon Clinical and Investigative medicine. Medecine Clinique et Experimentale 18 …, 1995 | 8 | 1995 |
| An intron c. 149‐2632T> A change in RHD is associated with aberrant transcription and very weak D phenotype. A Floch, S Vege, P Berardi, J Hannon, G Ochoa‐Garay, C Lomas‐Francis, ... Transfusion 62 (2), 2022 | 6 | 2022 |
